The U.S. bio-pharmaceutical industry is the best contributor to new drug developments in the global marketplace. In this highly innovation-driven industry, R&D managers make sense of strategic issues and take actions based on them. This study empirically validated R&D managerial cognitive interplay with R&D behavior and innovation. Furthermore, this study formulated the best-fitting innovative management model for achieving innovation. The outcome of this study essentially placed R&D managers in the center of innovation and refined R&D managerial impact on cognitive and behavioral process in the pursuit of innovation. Finally, this study provided R&D managers with the five predictors of innovation for them to be cognizant of how to efficiently increase innovation. This study revealed the significance of the R&D managerial model as it highlights the interwoven and multifaceted relationships between R&D managerial cognition, R&D behavior, and innovation.
Die Inhaltsangabe kann sich auf eine andere Ausgabe dieses Titels beziehen.
Dr. Rachel H. Kim is a pharmacist, consultant, researcher, journal editor, instructor, and author of management articles. She has been teaching strategic management and providing consulting services to Multinational Corporation in area of strategic management.
„Über diesen Titel“ kann sich auf eine andere Ausgabe dieses Titels beziehen.
Anbieter: Ria Christie Collections, Uxbridge, Vereinigtes Königreich
Zustand: New. In English. Artikel-Nr. ria9783639764116_new
Anzahl: Mehr als 20 verfügbar
Anbieter: preigu, Osnabrück, Deutschland
Taschenbuch. Zustand: Neu. Biotechnology Management from A Strategic Management Perspective | Strategic Cognition and Strategic Behavior of R&D Managers | Rachel Kim | Taschenbuch | 156 S. | Englisch | 2017 | SPS | EAN 9783639764116 | Verantwortliche Person für die EU: OmniScriptum GmbH & Co. KG, Bahnhofstr. 28, 66111 Saarbrücken, info[at]akademikerverlag[dot]de | Anbieter: preigu. Artikel-Nr. 104637676
Anzahl: 5 verfügbar